Login

Oyster Point Pharma, Inc. 8-K/A SEC Filings

Filed On Filing
13 Jan 2023 8-K/A: Termination of a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +5 more

On January 3, 2023 and in connection with the consummation of the Offer (as defined below) and the Merger (as defined below), Oyster Point prepaid in full all of its outstanding obligations in respect of principal, interest, expenses, fe...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support